Cargando…

Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes

Background. Besides their role in reverse cholesterol transport, HDL particles may affect the atherosclerotic process through the modulation of subclinical inflammation. HDL particles differ in size, composition, and, probably, anti-inflammatory properties. This hypothesis has never been explored in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Giuseppina T., Giandalia, Annalisa, Romeo, Elisabetta L., Alibrandi, Angela, Horvath, Katalin V., Asztalos, Bela F., Cucinotta, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167212/ https://www.ncbi.nlm.nih.gov/pubmed/25258627 http://dx.doi.org/10.1155/2014/607924

Ejemplares similares

Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome
por: Giandalia, Annalisa, et al.
Publicado: (2018)

Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
por: Russo, Giuseppina T., et al.
Publicado: (2017)

Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
por: Giandalia, Annalisa, et al.
Publicado: (2021)

Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus
por: Giandalia, A., et al.
Publicado: (2021)

Methotrexate Increases Skeletal Muscle GLUT4 Expression and Improves Metabolic Control in Experimental Diabetes
por: Russo, Giuseppina T., et al.
Publicado: (2012)

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
por: Kempen, Herman J., et al.
Publicado: (2014)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease
por: Asero, Clelia, et al.
Publicado: (2023)

Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population
por: Włodarczyk, Marta, et al.
Publicado: (2016)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes
por: Fera, Maria Teresa, et al.
Publicado: (2010)

Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
por: Choi, Seungbum, et al.
Publicado: (2013)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes
por: Giandalia, Annalisa, et al.
Publicado: (2022)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
por: Cedó, Lídia, et al.
Publicado: (2016)

Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins
por: Wang, Liyun, et al.
Publicado: (2014)

Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
por: Licata, Anna, et al.
Publicado: (2023)

Impact of Covid-19 Pandemic on the Effectiveness of Outpatient Counseling in Childhood Obesity Management
por: Corica, Domenico, et al.
Publicado: (2022)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
por: Wieczorek, Ewa, et al.
Publicado: (2021)

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease
por: Gliwińska, Anna, et al.
Publicado: (2022)

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
por: Borja, Mark S., et al.
Publicado: (2013)

Sex differences in HDL ApoC-III in American Indian youth
por: Blackett, Piers R, et al.
Publicado: (2012)

ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma
por: Braesch-Andersen, Sten, et al.
Publicado: (2014)

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
por: Cacciola, Irene, et al.
Publicado: (2021)

Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL
por: Cho, Kyung-Hyun
Publicado: (2022)

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
por: Gomaraschi, Monica, et al.
Publicado: (2011)

Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
por: Kido, Toshimi, et al.
Publicado: (2017)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome
por: Ng, Theodore W. K., et al.
Publicado: (2009)

The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease
por: Furtado, Jeremy D., et al.
Publicado: (2021)

Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins
por: Tsunoda, Fumiyoshi, et al.
Publicado: (2016)

ApoE and ApoE Nascent-Like HDL Particles at Model Cellular Membranes: Effect of Protein Isoform and Membrane Composition
por: Waldie, Sarah, et al.
Publicado: (2021)

The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study
por: Qin, Guangming, et al.
Publicado: (2015)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
Publicado: (1992)

Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks
por: Huang, Gang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j6vgld407mhguepcsb7oq8pca6